Review article · 2021 · Open access
Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design
BioDrugs, 35(6), 693–714 · Published 1 November 2021 · DOI 10.1007/s40259-021-00503-9
In brief
“Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design” is a 2021 review article by Araceli Rivera-Ordaz and 4 co-authors, published in BioDrugs. OpenAlex counts 47 citations as of 21 November 2026, which puts it in the top 8% of works published in 2021 by citations. It is open access under a CC BY-NC licence: the full text is free to read at BioDrugs.
- Citations
- 47
- Most cited in
- 2026 (15)
- Field-weighted impact
- 0.53
- References
- 134
- Authors
- 5
Abstract
Human induced pluripotent stem cells (hiPSCs) are manufactured as advanced therapy medicinal products for tissue replacement applications. With this aim, the feasibility of hiPSC large-scale expansion in existing bioreactor systems under current good manufacturing practices (cGMP) has been tested. Yet, these attempts have lacked a paradigm shift in culture settings and technologies tailored to hiPSCs, which jeopardizes their clinical translation. The best approach for industrial scale-up of high-quality hiPSCs is to design their manufacturing process by following quality-by-design (QbD) principles: a scientific, risk-based framework for process design based on relating product and process attributes to product quality. In this review, we analyzed the hiPSC expansion manufacturing process implementing the QbD approach in the use of bioreactors, stressing the decisive role played by the cell quantity, quality and costs, drawing key QbD concepts directly from the guidelines of the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rivera-Ordaz, A., Peli, V., Manzini, P., Barilani, M., & Lazzari, L. (2021). Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design. BioDrugs, 35(6), 693–714. https://doi.org/10.1007/s40259-021-00503-9
MLA 9
Rivera-Ordaz, Araceli, et al. “Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.” BioDrugs, vol. 35, no. 6, 2021, pp. 693–714. https://doi.org/10.1007/s40259-021-00503-9.
Chicago
Rivera-Ordaz, Araceli, Valeria Peli, Paolo Manzini, Mario Barilani, and Lorenza Lazzari. 2021. “Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.” BioDrugs 35 (6): 693–714. https://doi.org/10.1007/s40259-021-00503-9.
Harvard
Rivera-Ordaz, A. et al. (2021) ‘Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design’, BioDrugs, 35(6), pp. 693–714. doi:10.1007/s40259-021-00503-9.
IEEE
A. Rivera-Ordaz, V. Peli, P. Manzini, M. Barilani, and L. Lazzari, “Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design,” BioDrugs, vol. 35, no. 6, pp. 693–714, 2021, doi: 10.1007/s40259-021-00503-9.
BibTeX
@article{riveraordaz2021critical,
title = {{Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design}},
author = {Rivera-Ordaz, Araceli and Peli, Valeria and Manzini, Paolo and Barilani, Mario and Lazzari, Lorenza},
journal = {BioDrugs},
year = {2021},
volume = {35},
number = {6},
pages = {693--714},
doi = {10.1007/s40259-021-00503-9},
url = {https://doi.org/10.1007/s40259-021-00503-9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 2 | |
| 2023 | 6 | |
| 2024 | 14 | |
| 2025 | 10 | |
| 2026 | 15 |
Its field-weighted citation impact is 0.53: it has been cited 0.53 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- human induced pluripotent stem cells
- bioreactors
- quality by design
- cGMP production
- advanced therapy medicinal products
- process scale-up
- ICH guidelines
- clinical translation
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Rivera-Ordaz, A., Peli, V., Manzini, P., Barilani, M., & Lazzari, L. (2021). Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design. BioDrugs, 35(6), 693–714. https://doi.org/10.1007/s40259-021-00503-9
How many times has this paper been cited?
47 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at BioDrugs: sign in and open the PDF from this page.
Who wrote this paper?
Araceli Rivera-Ordaz, Valeria Peli, Paolo Manzini, Mario Barilani, Lorenza Lazzari.
What is the DOI of this paper?
10.1007/s40259-021-00503-9, permanently at https://doi.org/10.1007/s40259-021-00503-9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.